Medicamen Biotech Ltd Share Price – NSE  / BSE

Pharmaceuticals, Small Cap

Net profit of Medicamen Biotech declined 67.70% to Rs 1.35 crore in the quarter ended June 2024 as against Rs 4.18 crore during the previous quarter ended June 2023. Sales rose 2.65% to Rs 43.05 crore in the quarter ended June 2024 as against Rs 41.94 crore during the previous quarter ended June 2023.

Powered by Capital Market - Live News

Medicamen Biotech will hold a meeting of the Board of Directors of the Company on 13 August 2024.

Powered by Capital Market - Live News

Net profit of Medicamen Biotech declined 45.24% to Rs 2.13 crore in the quarter ended March 2024 as against Rs 3.89 crore during the previous quarter ended March 2023. Sales rose 22.37% to Rs 47.32 crore in the quarter ended March 2024 as against Rs 38.67 crore during the previous quarter ended March 2023.

For the full year,net profit declined 26.35% to Rs 10.93 crore in the year ended March 2024 as against Rs 14.84 crore during the previous year ended March 2023. Sales rose 27.29% to Rs 179.31 crore in the year ended March 2024 as against Rs 140.87 crore during the previous year ended March 2023.

Powered by Capital Market - Live News

Medicamen Biotech announced that the Board of Directors of the Company at its meeting held on 29 May 2024, has recommended a Final dividend of Rs.1 per share (i.e.10%), subject to the approval of the shareholders.

Powered by Capital Market - Live News